Mechanistically, we found that METTL9 promoted tumor progression by upregulating the expression of SLC7A11, which subsequently decreases lipid oxidative damage and enhances antioxidant capacity, thereby inhibiting tumor-cell ferroptosis. This evidence concerns the gene SLC7A11 and neoplasm.